Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › MA › Burlington › NPI 1396196341
NP / PA

Whitney, Jon

Whitney, Jon was paid $324K by Medicaid between Nov 2018 and May 2024, across 4 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 50% of everything it billed.

33Billing provider infoWHITNEY, JON
BURLINGTON, MA 01805
33aNPI1396196341assigned 06/30/2016
33bProvider typePhysician Assistant
28Total paid$324K
24GClaims6,018
24DCodes billed4
24AFirst – last monthNov 2018 – May 2024
Compared with peers

Next to other Physician Assistant providers in Massachusetts

Rank by total paid#13 of 272
Median peer was paid$6K
This provider vs. median53×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$5.0K$10K$15K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201853$3K
2020996$46K
20211,715$93K
20221,373$78K
20231,351$77K
2024incomplete530$27K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 50% 1,910 867 $164K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 30% 2,181 1,126 $97K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 17% 993 597 $54K
99406 2.8% 934 315 $9K

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.